HLA
KITE

Hamilton Lane Advisors’s Kite Pharma, Inc. KITE Stock Holding History

Hamilton Lane Advisors’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-22,504
Closed -$1.37M – 70
2015
Q2 		$1.37M Buy
+22,504
New +$1.28M 0.52% 33

Other funds holding KITE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
WCM
Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Hamilton Lane Advisors's KITE Position: Q3 2015 in Review

Hamilton Lane Advisors sold out of Kite Pharma, Inc. (KITE) in Q3 2015, closing a stake of 22,504 shares — an estimated $1.37M sold.

Hamilton Lane Advisors first reported a position in KITE in Q2 2015 and held it in 1 quarter. The position peaked at $1.37M in Q2 2015. 155 funds tracked by Wall St. Rank hold KITE as of Q3 2015.

  • Hamilton Lane Advisors reported no remaining Kite Pharma, Inc. position as of Q3 2015 after selling out during the quarter.
  • Hamilton Lane Advisors sold 22,504 Kite Pharma, Inc. shares in Q3 2015, an estimated $1.37M.
  • Hamilton Lane Advisors first reported a position in Kite Pharma, Inc. in Q2 2015 and held it in 1 quarter.
  • Hamilton Lane Advisors's Kite Pharma, Inc. position peaked at $1.37M in Q2 2015.
  • 155 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q3 2015.

Based on Hamilton Lane Advisors's 13F filing for Q3 2015, filed 19 Oct 2015.